SARS CoV 2 News and Research

RSS

Study shows increasing size of respiratory droplets under cold humid conditions

Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.

8 Nov 2020

Second wave of COVID-19 in UK has reached “critical” stage, says study

The current paper reports the preliminary findings of the sixth round of the REal-time Assessment of Community Transmission-1 (REACT-1) study, which has traced the path of the outbreak in England since May this year (2020).

8 Nov 2020

Universal nanoparticle platform may help in rapid development of a COVID-19 vaccine

A research group in China recently published a paper on the pre-print server bioRxiv* that reports the performance of a potentially universal nanoparticle platform that may prove useful for the rapid development of a COVID-19 vaccine, as well as other vaccines in the future.

8 Nov 2020

Research sheds light on how encapsulated viruses hijack protein production systems

Researchers from the Universities of Melbourne, York, Warwick and Oxford have shed light on how encapsulated viruses like hepatitis B, dengue and SARS-CoV-2 hijack the protein manufacturing and distribution pathways in the cell - they have also identified a potential broad spectrum anti-viral drug target to stop them in their tracks.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

People of color with rheumatic disease have worse COVID-19 outcomes

New research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized to treat their coronavirus infection, and are more likely to require invasive ventilator treatment

6 Nov 2020

Study shows low incidence of COVID-19 infection in people with rheumatic diseases

A new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected experience a mild course of illness.

6 Nov 2020

Research describes novel molecules designed to treat or prevent COVID-19 infection

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.

6 Nov 2020

COVID-19 hospitalizations and deaths skew towards older males of non-European ancestry

A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.

6 Nov 2020

Study shows iscan method could be effective for rapid COVID-19 testing

A simple COVID-19 test kit combines virus amplification with a CRISPR-Cas system for effective SARS-CoV-2 detection. The kit, called iSCAN, uses reagents that can be locally manufactured.

6 Nov 2020

Reducing the airborne transmission risk for SARS-CoV-2

Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press that accelerates peer review of COVID-19-related research preprints, is currently soliciting reviews of the following COVID-19 preprints.

6 Nov 2020

Study may help develop effective drugs against COVID-19

Scientists at the University of Cambridge, in collaboration with Justus-Liebig University, Germany, have uncovered how the genome of SARS-CoV-2 - the coronavirus that causes COVID-19 - uses genome origami to infect and replicate successfully inside host cells.

5 Nov 2020

Anxiety disorders increase among US citizens during COVID-19 pandemic

Scientists from the University of North Carolina and City University New York have recently revealed that a majority of United States citizens have suffered from anxiety disorders amid the coronavirus disease 2019 (COVID-19) pandemic. Financial adversity is one of the major causative factors for anxiety symptoms. The study is currently available on the medRxiv* preprint server.

5 Nov 2020

A digital CRISPR-based method for quick detection and absolute quantification of SARS-CoV-2

In a recent medRxiv* preprint manuscript, researchers from Singapore and the United States report the development of a digital CRISPR method for the sensitive, specific, and rapid detection of viral nucleic acids at a constant temperature, which could be exploited for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

5 Nov 2020

New Zealand case study shows room for improvement in genomic sequencing of COVID-19 outbreaks

Researchers in New Zealand, the United States and Australia have demonstrated the effectiveness of real-time genomic sequencing at tracking the re-emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New Zealand, in August this year.

5 Nov 2020

Pre-existing anti-IFN autoantibodies may worsen COVID-19 in lupus patients

“Our observations suggest that the presence of these autoantibodies may predispose SLE patients to infection with SARS-CoV-2 with a more severe presentation and represent an additional risk factor in this patient population,” write Sarthak Gupta and colleagues from the National Institute of Arthritis and Musculoskeletal and Skin Diseases in Bethesda, Maryland.

5 Nov 2020

Persistent and extensive lung damage seen in COVID-19 patients

A team of researchers at the University of Trieste in Italy aimed to determine the extent and the causes of lung damage from COVID-19 to better understand the pathological correlates of the disease.

5 Nov 2020

Llama antibodies could be a potent nanoweapon against COVID-19

Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.

5 Nov 2020

Occupational risk of COVID-19 in 3.5 million Norwegians

A team of researchers at the Norwegian Institute of Public Health have sought to determine which among workers and employees have higher odds of COVID-19 infection in the first and second waves of the outbreak.

5 Nov 2020

Children produce different antibodies in response to infection with new coronavirus

Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

5 Nov 2020

SARS CoV 2 News and Research

Study shows increasing size of respiratory droplets under cold humid conditions

Second wave of COVID-19 in UK has reached “critical” stage, says study

Universal nanoparticle platform may help in rapid development of a COVID-19 vaccine

Research sheds light on how encapsulated viruses hijack protein production systems

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

People of color with rheumatic disease have worse COVID-19 outcomes

Study shows low incidence of COVID-19 infection in people with rheumatic diseases

Research describes novel molecules designed to treat or prevent COVID-19 infection

COVID-19 hospitalizations and deaths skew towards older males of non-European ancestry

Study shows iscan method could be effective for rapid COVID-19 testing

Reducing the airborne transmission risk for SARS-CoV-2

Study may help develop effective drugs against COVID-19

Anxiety disorders increase among US citizens during COVID-19 pandemic

A digital CRISPR-based method for quick detection and absolute quantification of SARS-CoV-2

New Zealand case study shows room for improvement in genomic sequencing of COVID-19 outbreaks

Pre-existing anti-IFN autoantibodies may worsen COVID-19 in lupus patients

Persistent and extensive lung damage seen in COVID-19 patients

Llama antibodies could be a potent nanoweapon against COVID-19

Occupational risk of COVID-19 in 3.5 million Norwegians

Children produce different antibodies in response to infection with new coronavirus

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News